Skip to main content

Table 6 Odds ratios and 95% confidence intervals showing the association of metabolic comorbidities and the risk of recurrent metastatic disease in pre- (N = 306) and post-menopausal breast cancer patients (N = 775) using binominal logistic regression. All variables were included in the multivariable analysis

From: Metabolic comorbidities and the association with risks of recurrent metastatic disease in breast cancer survivors

Variables Pre-menopause (N = 306) Post-menopause (N = 775)
OR 95%CI P value OR 95%CI P value
DM or glucose intolerance 1.425 0.760–2.671 0.269 1.569 1.110–2.217 0.011
Dyslipidemia 0.816 0.426–1.565 0.541 1.142 0.805–1.621 0.456
Hypertension 0.686 0.395–1.191 0.181 1.151 0.828–1.600 0.401
BMI risk (> 27.7) 0.629 0.314–1.263 0.193 1.229 0.851–1.775 0.271
DM/glucose intolerance + Dyslipidemia 1.935 0.774–4.839 0.546 1.714 1.134–2.591 0.011
DM/glucose intolerance + Hypertension 1.257 0.610–2.592 0.535 1.705 1.191–2.441 0.004
Dyslipidemia + Hypertension 0.785 0.395–1.559 0.899 1.240 0.871–1.765 0.233
Dyslipidemia + BMI risk 0.602 0.164–2.211 0.445 1.133 0.715–1.793 0.595
Hypertension + BMI risk 0.335 0.097–1.161 0.084 1.317 0.881–1.970 0.180
DM/glucose intolerance + BMI risk 0.274 0.034–2.224 0.226 1.404 0.827–2.384 0.209
≥3 metabolic comorbidities 1.083 0.489–2.399 0.845 1.967 1.377–2.810 < 0.001
Any metabolic comorbidity 0.727 0.444–1.191 0.206 1.088 0.775–1.526 0.626